News

Filter

Current filters:

North America

176 to 185 of 97223 results

Orexo presents new Ph III data for Zubsolv

07-12-2014

The US subsidiary of Swedish drug developer Orexo says that, in the ISTART Phase III study, Zubsolv (buprenorphine…

NeurologicalOrexoPharmaceuticalResearchSuboxoneZubsolv

Bayer files for European approval of hemophilia A drug BAY 81-8973

06-12-2014

German pharma major Bayer has filed an application for marketing authorization to the European Medicines…

BAY 81-8973BayerEuropeHematologyPharmaceuticalRegulation

FDA advisory panel backs Actavis’ ceftazidime-avibactam

06-12-2014

Ireland-headquartered generic drugs major Actavis says that the Anti-Infective Drugs Advisory Committee…

ActavisAntibiotics and Infectious diseasesAstraZenecaceftazidime-avibactamPharmaceuticalRegulationUSA

EMA update on review of studies performed at GVK Biosciences site in Hyderabad, India

06-12-2014

Some European Union member states have decided to suspend the marketing authorizations of medicines that…

EuropeGVK BiosciencesIndiaPharmaceuticalRegulationResearch

Turning a constraint into an enabler: transparency round-table at Veeva's commercial summit 2014

Turning a constraint into an enabler: transparency round-table at Veeva's commercial summit 2014

05-12-2014

In one of the opening sessions, cloud-based life sciences provider Veeva’s co-founder and president…

BMI SystemEuropeInterviewsPharmaceuticalRegulationVeeva

Mixed findings from IQWiG on added benefit for Eliquis

05-12-2014

The German Institute for Quality and Efficiency in Health Care (IQWiG) has examined a dossier on Eliquis…

Bristol-Myers SquibbCardio-vascularEliquisGermanyPfizerPharmaceuticalPricingRegulation

Patient access to novel non-insulin treatments is sub-optimal in China

05-12-2014

With respect to the treatment of type 2 diabetes in China, patient access to premium-priced agents is…

AstraZenecaByettaChinaDiabetesHealthcareJanuviaMarkets & MarketingMerck & CoPharmaceutical

Takeda receives Breakthrough designation for ixazomib

Takeda receives Breakthrough designation for ixazomib

05-12-2014

Japanese drug major Takeda Pharmaceutical’s has been granted Breakthrough Therapy designation from…

ixazomibPharmaceuticalRare diseasesRegulationTakeda PharmaUSA

Sanofi accused of $34 million kickbacks by former paralegal employee

Sanofi accused of $34 million kickbacks by former paralegal employee

05-12-2014

Allegations have been made that French drug major Sanofi and members of its executive took part in a…

FranceLantusLegalNephrology and HepatologyPharmaceuticalSanofi

176 to 185 of 97223 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top